Circadian Biology: How Your Body Clock Controls Health, Disease, and Longevity

Circadian biology is the scientific study of endogenous biological oscillations with a period of approximately 24 hours — rhythms that govern the timing of nearly every physiological process in living organisms, from single-celled cyanobacteria to human beings. The word circadian derives from the Latin circa diem, meaning "about a day." These are not passive responses to day and night; they are active, self-generated programmes encoded in the genome that would continue running even if you were placed in a cave with no external time cues. This self-sustaining property is called free-running, and it demonstrates that the body possesses a genuine internal clock, not merely a light-detection system.

The field became incontrovertibly central to medicine in 2017, when Jeffrey Hall, Michael Rosbash, and Michael Young were awarded the Nobel Prize in Physiology or Medicine for their molecular dissection of the circadian clock in Drosophila. Their work revealed the core transcription-translation feedback loop that drives all circadian rhythms across animal species — a loop conserved from fruit flies to humans with remarkable fidelity. This discovery reframed circadian disruption from a nuisance (jet lag, shift-work fatigue) into a bona fide driver of metabolic disease, cancer biology, immune dysfunction, and accelerated ageing.

What makes circadian biology especially important clinically is its scope. Clock genes — including CLOCK, BMAL1, PER1, PER2, PER3, CRY1, and CRY2 — are expressed in virtually every tissue in the body, from the liver and pancreas to the heart, lungs, skin, gut epithelium, and immune cells. Approximately 80% of protein-coding genes show circadian oscillation in at least one tissue, according to a landmark 2018 analysis in the Proceedings of the National Academy of Sciences. This means that nearly every drug target, biomarker, and physiological process has a time-of-day dimension — a fact with profound implications for pharmacology, surgery, vaccination, and preventive medicine.

The mammalian molecular clock operates as an interlocking pair of transcription-translation feedback loops that complete one full cycle over approximately 24 hours. In the primary loop, two transcription factors — CLOCK and BMAL1 — form a heterodimer and bind to E-box enhancer sequences in the promoters of the Period genes (PER1, PER2, PER3) and Cryptochrome genes (CRY1, CRY2), driving their transcription. As PER and CRY protein levels accumulate over several hours, they form a repressor complex that translocates back into the nucleus and inhibits the CLOCK:BMAL1 complex — thereby shutting off their own transcription. As PER and CRY proteins are then degraded by kinases (notably CK1delta and CK1epsilon), inhibition is relieved, and the cycle begins again. This self-limiting oscillation has an intrinsic period of roughly 24.2 hours in humans, requiring daily resetting by external time cues to stay precisely aligned to the solar day.

A secondary stabilising loop involves the nuclear receptors REV-ERB alpha and ROR alpha, which regulate BMAL1 transcription. REV-ERB alpha, activated by CLOCK:BMAL1, represses BMAL1 expression; ROR alpha activates it. This interlocking architecture buffers the clock against noise and temperature fluctuations, giving it the robustness needed to function reliably in warm-blooded organisms across varying metabolic states. Post-translational modifications — phosphorylation, acetylation, and ubiquitination of clock proteins — fine-tune the period length and amplitude of the oscillation with extraordinary precision. Mutations in these modifier enzymes produce recognisable clinical phenotypes: gain-of-function mutations in CK1delta shorten the clock period and cause familial advanced sleep phase disorder, while loss-of-function mutations lengthen it and produce delayed sleep phase disorder.

The master clock in the suprachiasmatic nucleus (SCN) — a paired nucleus of approximately 20,000 neurons in the anterior hypothalamus directly above the optic chiasm — coordinates all peripheral tissue clocks through multiple output pathways. Neural signals travel via the autonomic nervous system to peripheral organs; hormonal signals, particularly the cortisol rhythm (peaking near wake time) and the melatonin rhythm (peaking in the middle of the night), broadcast timing information systemically; and body temperature rhythms (core temperature is approximately 0.5°C higher during the day than at night) serve as a powerful synchronising signal for peripheral tissues. When food availability, social behaviour, or artificial light decouple these signals from the environmental day-night cycle, peripheral clocks in the liver, gut, and muscle can drift out of phase with the SCN — a state of internal circadian misalignment now recognised as a major contributor to metabolic disease.

The word zeitgeber — German for "time-giver" — refers to any environmental signal capable of synchronising an endogenous circadian clock to an external cycle. Light is overwhelmingly the dominant zeitgeber for the human SCN, and understanding how it works at the cellular level is essential for anyone seeking to apply circadian science practically. The discovery of a third class of retinal photoreceptors — the intrinsically photosensitive retinal ganglion cells (ipRGCs) — was a watershed moment in this understanding. Unlike rods and cones, which communicate visual information to the visual cortex via bipolar cells, ipRGCs express the photopigment melanopsin (OPN4) and send axons directly to the SCN via the retinohypothalamic tract. They are most sensitive to short-wavelength light in the blue range, with peak sensitivity around 480 nm — the wavelength that dominates clear daytime sky and is heavily represented in LED and smartphone screens.

Light-induced SCN activation triggers a cascade of molecular events. Glutamate released at the retinohypothalamic synapse activates NMDA receptors in SCN neurons, triggering calcium influx, nitric oxide synthesis, and ultimately the rapid induction of PER1 and PER2 expression. Whether this induction advances or delays the clock depends entirely on when light arrives relative to the current clock phase. Light arriving in the early biological night (first 4-6 hours after habitual sleep onset) strongly delays the clock — pushing sleep and wake later. Light arriving in the late biological night or early morning advances the clock — promoting earlier sleep and wake times. This phase-response curve to light is the mechanistic basis of jet lag, shift-work adaptation, and all practical light therapy interventions.

Intensity and duration both matter substantially. A landmark 2001 study by Czeisler and colleagues demonstrated that even room-level light (~100 lux) can suppress melatonin and shift the circadian phase — a finding that overturned the prior assumption that humans were relatively insensitive to artificial light. Outdoor midday light reaches 50,000-100,000 lux; a bright office interior reaches 300-500 lux; a smartphone screen held at arm's length produces 50-500 lux depending on brightness settings. The biological consequence is that modern indoor living represents a light environment profoundly different from the one under which human circadian biology evolved — chronically dim days and chronically bright evenings — and this mismatch is now considered a plausible mechanistic contributor to the epidemic of sleep disorders, metabolic disease, and mood dysregulation in industrialised populations.

The health consequences of chronic circadian misalignment are now among the best-characterised environmental disease risk factors in epidemiology. Shift work — affecting approximately 20% of the working population in industrialised nations — is the most extensively studied model of chronic circadian disruption. A 2019 meta-analysis of 28 prospective cohort studies (n = 3.9 million) found that night shift workers had a 29% higher risk of obesity, 51% higher risk of abdominal obesity, and 37% higher risk of metabolic syndrome compared to day workers — even after controlling for dietary differences and physical activity. The mechanisms include disrupted insulin secretion timing (the pancreatic beta cell clock gates insulin release to align with anticipated meal times), impaired glucose tolerance when food is consumed at the biological night, and elevated evening cortisol that drives visceral adipogenesis.

The cancer evidence is particularly striking. The International Agency for Research on Cancer classified shift work involving circadian disruption as a Group 2A probable carcinogen in 2007, based on sufficient evidence in animal models and limited-but-consistent human epidemiological data. Subsequent large prospective studies have strengthened this classification: the Nurses' Health Study (n = 78,562, 22 years of follow-up) found that women who worked rotating night shifts for 30 or more years had a 36% higher risk of colorectal cancer and a statistically significant elevation in breast cancer risk. Mechanistically, circadian disruption suppresses the nocturnal melatonin surge (which has direct oncostatic effects), dysregulates immune surveillance by reducing natural killer cell activity during the night, and impairs the cell-cycle checkpoint proteins — including p53 and the DNA damage response kinase ATM — that contain circadian oscillation and are critical for tumour suppression.

Cardiovascular risk follows a similar pattern. A 2019 European Heart Journal analysis of 189,000 participants across 11 prospective studies found that shift workers had a 17% higher risk of coronary artery disease and a 26% higher risk of any cardiovascular event. The putative mechanisms include chronic sympathetic nervous system activation during forced wakefulness, elevated evening cortisol and inflammatory cytokines (IL-6, TNF-alpha), hypertension driven by disrupted nocturnal blood pressure dipping, and dyslipidaemia from mistimed meal-induced triglyceride elevation. Social jet lag — the discrepancy between biological sleep timing and social schedule timing that affects people who sleep late on weekends and early on weekdays — has also been linked to a 28% higher risk of cardiovascular disease in a study of over 84,000 participants in the UK Biobank, indicating that even subclinical circadian misalignment carries meaningful cardiovascular cost.

Cognitive and psychiatric consequences are equally well-documented. Circadian disruption accelerates Alzheimer's disease pathology in animal models by impairing glymphatic waste clearance — the brain's cerebrospinal fluid-driven flushing system that clears amyloid-beta and tau predominantly during slow-wave sleep. Population studies in humans show that irregular sleep timing is associated with higher amyloid burden on PET imaging, and longitudinal data from the ARIC cohort found that poor sleep quality in midlife predicted a 30-40% higher dementia incidence 25 years later. Mood disorders show the highest association of all: disrupted circadian rhythms are near-universal in bipolar disorder, major depressive disorder, and seasonal affective disorder — and circadian phase correction via light therapy, sleep phase manipulation, and social rhythm therapy is now a first-line adjunct treatment in evidence-based psychiatry.

Chronomedicine — also called chronotherapy or chronopharmacology — is the science of optimising the timing of medical interventions based on the patient's circadian phase. The field has moved from theoretical to clinically actionable across multiple domains. In oncology, the timing of chemotherapy infusion relative to the patient's circadian phase can substantially alter both efficacy and toxicity. A landmark trial by Francis Levi and colleagues found that colorectal cancer patients treated with oxaliplatin delivered at circadian-optimised times (timed to align with peak hepatic detoxification enzyme activity and tumour cell-cycle vulnerability) showed 41% higher tumour response rates and significantly reduced peripheral neuropathy compared to flat-infusion controls. Circadian timing of immune checkpoint inhibitors is now an active research priority following a 2021 Nature Communications study showing that PD-1 inhibitor response rates were more than doubled in patients infused in the morning compared to afternoon — an effect attributed to circadian variation in T-cell trafficking and tumour immune infiltration.

Vaccine immunogenicity is strongly time-of-day dependent. A 2019 study in the Journal of Biological Rhythms found that morning influenza vaccination (9:00-11:00 AM) produced antibody titres 4-fold higher than afternoon vaccination (15:00-17:00 PM) in older adults — a difference attributable to the morning peak in monocyte and dendritic cell activity that governs antigen presentation. These findings have direct practical implications for mass vaccination programmes. Blood pressure medication timing is another well-established application: bedtime dosing of ACE inhibitors and calcium channel blockers produces significantly better nocturnal blood pressure dipping and lower cardiovascular event rates than morning dosing, as demonstrated in the HYGIA Chronotherapy Trial (n = 19,084), which found a 45% reduction in major cardiovascular events with bedtime antihypertensive administration.

Surgical outcomes also vary with circadian phase. A 2018 Lancet study analysing 596 aortic valve replacements found that afternoon surgery was associated with a 50% lower rate of major adverse cardiac events compared to morning surgery — an effect mediated by the circadian variation in cardiomyocyte ischaemia-reperfusion tolerance, which peaks in the early afternoon due to clock-regulated expression of protective proteins including ROR alpha and Rev-erb alpha. As precision medicine platforms increasingly incorporate wearable physiological data, real-time circadian phase estimation using algorithms applied to wrist actigraphy, heart rate variability, and skin temperature is becoming feasible — potentially enabling personalised chronomedicine at scale.

1. Morning light exposure. The single most impactful circadian intervention for most people is obtaining bright natural light exposure within 30-60 minutes of waking. A 2022 Current Biology study found that outdoor morning light (even on a cloudy day — overcast outdoor light typically delivers 1,000-10,000 lux) shortened sleep onset latency by a mean of 14 minutes and shifted the dim-light melatonin onset 30 minutes earlier within one week. The effect is robust across chronotypes and significantly stronger than afternoon light exposure. Practical protocol: 10-20 minutes outdoors without sunglasses (peripheral retinal exposure is important) within the first hour of waking, before any bright indoor light exposure. On days when outdoor light is unavailable, a 10,000 lux broad-spectrum light therapy box delivers a validated alternative.

2. Evening light reduction. Avoiding blue-enriched bright light in the 2-3 hours before intended sleep onset is mechanistically the most direct circadian hygiene intervention. A 2017 PNAS study by Gooley and colleagues demonstrated that reading on a light-emitting device before bed suppressed melatonin onset by 90 minutes, delayed the circadian clock by 1.5 hours, and reduced morning alertness — all reversed by switching to a printed book under dim light. Practical approaches include blue-light blocking glasses (effective if they attenuate wavelengths below 530 nm by at least 80%), amber-hued lighting in living areas after sunset, and automatic Night Shift settings on devices set to maximum warmth. Complete darkness during sleep — using blackout curtains or an eye mask — eliminates the residual light effects on melatonin maintenance that occur even through closed eyelids at typical streetlight levels.

3. Sleep and wake time consistency. Irregular sleep timing — varying wake time by more than 60 minutes across the week — disrupts peripheral clock synchronisation even when total sleep duration is adequate. The Sleep Regularity Index (SRI), developed from UK Biobank actigraphy data on 60,977 participants, showed that each 10-point increase in sleep regularity (scale 0-100) was associated with a 20% reduction in all-cause mortality — a larger effect size than sleep duration in the same dataset. Consistent wake time is the most powerful anchor: since light-driven SCN resetting relies on a stable dawn signal, waking at the same time daily provides the most consistent circadian entrainment even when bedtime varies modestly.

4. Time-restricted eating aligned with daylight. The liver, pancreas, and gut each contain peripheral clocks that are strongly entrained by food timing — in some tissues, more powerfully than by light. Eating within a consistent 8-10 hour window aligned with daytime (first meal within 1-2 hours of waking, final meal 3 or more hours before sleep) synchronises peripheral metabolic clocks with the SCN. A 2020 Cell Metabolism RCT in men with metabolic syndrome found that 10-week time-restricted eating (10-hour window) reduced systolic blood pressure, body weight, insulin resistance, and atherogenic lipids compared to ad libitum eating — without any prescribed caloric restriction. Eating at the biological night — which occurs in night shift workers and many late-evening eaters — drives peripheral clock desynchrony, impairs insulin secretion timing, and elevates postprandial glucose by 17-29% compared to the same meal consumed at noon, as demonstrated in controlled inpatient studies.

5. Core body temperature management. Sleep onset requires a drop in core body temperature of approximately 1°C. This cooling is achieved naturally by peripheral vasodilation (heat is dissipated through the hands and feet), and it is driven by the circadian clock via suppression of the thermoregulatory set-point in the late afternoon. Sleeping environments above 20°C (68°F) impair slow-wave sleep depth and reduce the duration of restorative sleep stages. Practical interventions include setting bedroom temperature to 16-19°C, wearing warm socks (paradoxically accelerates sleep onset by promoting peripheral vasodilation and heat loss), and warm baths or showers 1-2 hours before bed (the subsequent rebound cooling accelerates sleep onset by 36% in a meta-analysis of 17 studies).

The relationship between circadian function and lifespan is now well-established in model organisms and increasingly supported in human data. In Drosophila, mutations abolishing circadian rhythms reduce lifespan by 15-20%. In mice, SCN lesioning — which eliminates the master clock signal to peripheral tissues — accelerates ageing phenotypes including sarcopenia, immune senescence, and tumour development. In humans, the UK Biobank actigraphy data provide the largest longitudinal circadian-longevity dataset: irregular circadian rest-activity rhythms are associated with 40% higher all-cause mortality, 22% higher cardiovascular mortality, and significantly accelerated biological ageing as measured by both epigenetic clocks and inflammatory marker composites.

The mechanistic links between circadian disruption and biological ageing are multiple and synergistic. Clock gene expression of BMAL1 and CLOCK directly regulates the transcription of NAD+ biosynthesis enzymes (particularly NAMPT), and NAD+ is the essential co-factor for the sirtuin family of longevity-associated deacetylases (SIRT1-7) and the DNA repair enzyme PARP1. Circadian disruption reduces NAD+ availability, impairing sirtuin-mediated mitochondrial quality control and DNA damage repair — two of the twelve recognised hallmarks of ageing. CLOCK:BMAL1 also directly regulates p21 and p16 expression at the G1/S cell-cycle checkpoint, meaning that circadian disruption impairs the cellular senescence surveillance that prevents the accumulation of dysfunctional senescent cells — another hallmark of ageing with outsized inflammatory consequences.

Conversely, maintaining strong circadian amplitude — the magnitude of the oscillation between peak and trough expression of clock genes — appears to be protective. Older adults consistently show reduced circadian amplitude in core body temperature, melatonin, cortisol, and activity rhythms, a phenomenon called circadian dampening that accelerates in the years preceding clinical decline. Interventions that reinforce circadian amplitude — including morning light therapy, physical exercise (which has potent zeitgeber effects via temperature and feeding cues), and social engagement that anchors timing — are among the most robust correlates of healthy ageing in longitudinal geriatric cohorts.